The dopamine D3 receptor as a key target for antipsychotics.

The third dopamine receptor (D3) as a novel target for antipsychotics.

Dopamine D3 receptors as a therapeutic target for methamphetamine dependence.

Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics.

Dopamine D3 receptor agonists as pharmacological tools.

Dopamine D3 Receptor Antagonists as Potential Therapeutics for the Treatment of Neurological Diseases.

Abnormalities of Dopamine D3 Receptor Signaling in the Diseased Brain.

Alternative transcripts of the rat and human dopamine D3 receptor.

Estimating dopamine D(2) receptor occupancy for doses of 8 antipsychotics: a meta-analysis: a reply.

Receptor-specific antisera as probes for the D2-dopamine receptor.

Glycyrrhetinic acid and E.resveratroloside act as potential plant derived compounds against dopamine receptor D3 for Parkinson's disease: a pharmacoinformatics study.

Biodistribution studies of two 18F-labeled pyridinylphenyl amides as subtype selective radioligands for the dopamine D3 receptor.

Ammonia Induces Autophagy through Dopamine Receptor D3 and MTOR.

Dopamine D3 Receptor Mediates Preadolescent Stress-Induced Adult Psychiatric Disorders.

Analysis of Human Dopamine D3 Receptor Quaternary Structure.

Dopamine D3 Receptor Availability Is Associated with Inflexible Decision Making.

Dopamine receptor D3 deficiency results in chronic depression and anxiety.

Primary vitamin D receptor target genes as biomarkers for the vitamin D3 status in the hematopoietic system.

Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptor.

Identifying Medication Targets for Psychostimulant Addiction: Unraveling the Dopamine D3 Receptor Hypothesis.

Chiral Resolution and Serendipitous Fluorination Reaction for the Selective Dopamine D3 Receptor Antagonist BAK2-66.

Recent methods for measuring dopamine D3 receptor occupancy in vivo: importance for drug development.

Further characterization of quinpirole-elicited yawning as a model of dopamine D3 receptor activation in male and female monkeys.

Optimizing perioperative mechanical ventilation as a key quality improvement target.

IGF1R as a Key Target in High Risk, Metastatic Medulloblastoma.

Suggest Documents

The third dopamine receptor (D3) as a novel target for antipsychotics.

Dopamine D3 receptors as a therapeutic target for methamphetamine dependence.

Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics.

Dopamine D3 receptor agonists as pharmacological tools.

Dopamine D3 Receptor Antagonists as Potential Therapeutics for the Treatment of Neurological Diseases.

Abnormalities of Dopamine D3 Receptor Signaling in the Diseased Brain.

Alternative transcripts of the rat and human dopamine D3 receptor.

Estimating dopamine D(2) receptor occupancy for doses of 8 antipsychotics: a meta-analysis: a reply.

Receptor-specific antisera as probes for the D2-dopamine receptor.

Glycyrrhetinic acid and E.resveratroloside act as potential plant derived compounds against dopamine receptor D3 for Parkinson's disease: a pharmacoinformatics study.

Biodistribution studies of two 18F-labeled pyridinylphenyl amides as subtype selective radioligands for the dopamine D3 receptor.

Ammonia Induces Autophagy through Dopamine Receptor D3 and MTOR.

Dopamine D3 Receptor Mediates Preadolescent Stress-Induced Adult Psychiatric Disorders.

Analysis of Human Dopamine D3 Receptor Quaternary Structure.

Dopamine D3 Receptor Availability Is Associated with Inflexible Decision Making.

Dopamine receptor D3 deficiency results in chronic depression and anxiety.

Primary vitamin D receptor target genes as biomarkers for the vitamin D3 status in the hematopoietic system.

Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptor.

Identifying Medication Targets for Psychostimulant Addiction: Unraveling the Dopamine D3 Receptor Hypothesis.

Chiral Resolution and Serendipitous Fluorination Reaction for the Selective Dopamine D3 Receptor Antagonist BAK2-66.

Recent methods for measuring dopamine D3 receptor occupancy in vivo: importance for drug development.

Further characterization of quinpirole-elicited yawning as a model of dopamine D3 receptor activation in male and female monkeys.

Optimizing perioperative mechanical ventilation as a key quality improvement target.

IGF1R as a Key Target in High Risk, Metastatic Medulloblastoma.

The dopamine D3 receptor as a key target for antipsychotics.

Recommend Documents

Follow Us